The Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis: A Meta-Analysis
Table 2
Subgroup analysis based on different definitions of Tregs in PB of patients with AS.
Definition of Tregs
Number of studies
Test of association
Test of heterogeneity
Egger’s test
SMD
95% CI
value
value
value
Single CD25-positive
6
0.736
(0.138, 1.334)
0.016
80.7%
<0.001
0.72
0.513
CD4+CD25+
1
0.846
(0.401, 1.291)
<0.001
–
–
–
–
CD4+CD25high
4
0.892
(−0.078, 1.862)
0.071
87%
<0.001
2.74
0.112
CD4+CD25bright
1
0.123
(−0.596, 0.842)
0.737
–
–
–
–
Associated with FOXP3-positive
18
−1.004
(−1.966, −0.042)
0.041
97.9%
<0.001
0.97
0.795
CD4+FOXP3+
3
0.383
(−0.663, 1.429)
0.473
90.4%
<0.001
−11.62
0.143
CD4+CD25+FOXP3+
9
−2.856
(−4.645, −1.066)
0.002
98.6%
<0.001
6.06
0.42
CD4+CD25highFOXP3+
3
0.868
(−0.756, 2.492)
0.295
92.6%
<0.001
2.91
0.862
CD4+CD25low/−FOPX3+
3
0.683
(0.161, 1.206)
0.01
68.4%
0.042
9.58
0.783
Associated with CD127-negative
4
−1.003
(−1.713, −0.294)
0.006
73.1%
0.011
−0.37
0.747
CD4+CD25highCD127low/−
1
−1.812
(−2.648, −0.977)
<0.001
–
–
–
–
CD4+CD25+CD127low
2
−1.12
(−1.605, −0.635)
<0.001
0.0%
0.486
–
–
CD4+CD25+CD127−
1
−0.004
(−0.751, 0.744)
0.992
–
–
–
–
PB: peripheral blood; AS: ankylosing spondylitis; SMD: standard mean difference; CI: confidence interval; :-squared index. Magnitude of Cohen’s effect size (SMD): 0.2–0.5, small effect; 0.5–0.8, medium effect; and ≥0.8, large effect.